ONWARD MEDICAL BV EO -12 Asset Resilience Ratio

Latest as of June 2024: 16.01%

ONWARD MEDICAL BV EO -12 asset resilience ratio. ONWARD MEDICAL BV EO -12 (63E) has an Asset Resilience Ratio of 16.01% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 63E cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€7.50 Million

≈ $8.77 Million USD Cash + Short-term Investments

Total Assets

€46.85 Million

≈ $54.78 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of ONWARD MEDICAL BV EO -12 (2022–2022)

Asset resilience ratio of ONWARD MEDICAL BV EO -12 from 2022 to 2022. This chart shows how ONWARD MEDICAL BV EO -12's Asset Resilience Ratio has changed over time. Read 63E total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down ONWARD MEDICAL BV EO -12's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 63E current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€7.50 Million	16.01%
Total Liquid Assets	€7.50 Million	16.01%

Asset Resilience Insights

Good Liquidity Position: ONWARD MEDICAL BV EO -12 maintains a healthy 16.01% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

ONWARD MEDICAL BV EO -12 Industry Peers by Asset Resilience Ratio

Compare ONWARD MEDICAL BV EO -12's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

ONWARD MEDICAL BV EO -12 Asset Resilience Ratio by Year (2022–2022)

ONWARD MEDICAL BV EO -12 asset resilience ratio by year from 2022 to 2022. The table below shows the annual Asset Resilience Ratio data for ONWARD MEDICAL BV EO -12.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	26.11%	€20.00 Million ≈ $23.38 Million	€76.59 Million ≈ $89.55 Million	--

pp = percentage points

About ONWARD MEDICAL BV EO -12

F:63E Germany Biotechnology

Market Cap

$157.86 Million

€135.02 Million EUR

Market Cap Rank

#17262 Global

#1630 in Germany

Share Price

€1.94

Change (1 day)

-5.96%

52-Week Range

€1.94 - €4.83

All Time High

€12.92